{{Rsnum
|rsid=11906854
|Gene=PHF20
|Chromosome=20
|position=35795712
|Orientation=plus
|GMAF=0.1543
|Gene_s=PHF20
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 77.0 | 22.1 | 0.9
| HCB | 84.7 | 15.3 | 0.0
| JPT | 71.7 | 27.4 | 0.9
| YRI | 58.9 | 35.6 | 5.5
| ASW | 70.2 | 28.1 | 1.8
| CHB | 84.7 | 15.3 | 0.0
| CHD | 71.6 | 26.6 | 1.8
| GIH | 65.3 | 31.7 | 3.0
| LWK | 58.2 | 39.1 | 2.7
| MEX | 75.9 | 19.0 | 5.2
| MKK | 55.1 | 37.2 | 7.7
| TSI | 67.6 | 30.4 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23793025
  |Trait=Migraine - clinic-based
  |Title=Genome-wide meta-analysis identifies new susceptibility loci for migraine.
  |RiskAllele=G
  |Pval=7E-6
  |OR=1.17
  |ORtxt=[1.09-1.26]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}